The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Therapeutic Vaccines Market Research Report 2025

Global Therapeutic Vaccines Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1907634

No of Pages : 81

Ask Your Query

Report Description
Table of Content

Synopsis

The global Therapeutic Vaccines market was valued at US$ 31040 million in 2023 and is anticipated to reach US$ 117470 million by 2030, witnessing a CAGR of 20.6% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Vaccines.

Report Scope

The Therapeutic Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies

Segment by Type

Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine

Segment by Application

Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Therapeutic Vaccines Market Overview
1.1 Product Overview and Scope of Therapeutic Vaccines
1.2 Therapeutic Vaccines Segment by Type
1.2.1 Global Therapeutic Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Peptide Therapeutic Vaccine
1.2.3 Cell Therapeutic Vaccine
1.2.4 Nucleic Acid Therapeutic Vaccine
1.3 Therapeutic Vaccines Segment by Application
1.3.1 Global Therapeutic Vaccines Market Value by Application: (2024-2030)
1.3.2 Oncotherapy
1.3.3 Hepatitis B
1.3.4 Tuberculosis
1.3.5 Herpes Simplex Virus
1.3.6 Others
1.4 Global Therapeutic Vaccines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Vaccines Revenue 2019-2030
1.4.2 Global Therapeutic Vaccines Sales 2019-2030
1.4.3 Global Therapeutic Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Vaccines Market Competition by Manufacturers
2.1 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Vaccines, Product Type & Application
2.7 Therapeutic Vaccines Market Competitive Situation and Trends
2.7.1 Therapeutic Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Vaccines Players Market Share by Revenue
2.7.3 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Vaccines Retrospective Market Scenario by Region
3.1 Global Therapeutic Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Vaccines Global Therapeutic Vaccines Sales by Region: 2019-2030
3.2.1 Global Therapeutic Vaccines Sales by Region: 2019-2024
3.2.2 Global Therapeutic Vaccines Sales by Region: 2025-2030
3.3 Global Therapeutic Vaccines Global Therapeutic Vaccines Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Vaccines Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Vaccines Revenue by Region: 2025-2030
3.4 North America Therapeutic Vaccines Market Facts & Figures by Country
3.4.1 North America Therapeutic Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Vaccines Sales by Country (2019-2030)
3.4.3 North America Therapeutic Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Vaccines Market Facts & Figures by Country
3.5.1 Europe Therapeutic Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Vaccines Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Therapeutic Vaccines Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic Vaccines Sales by Type (2019-2030)
4.1.1 Global Therapeutic Vaccines Sales by Type (2019-2024)
4.1.2 Global Therapeutic Vaccines Sales by Type (2025-2030)
4.1.3 Global Therapeutic Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Vaccines Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Vaccines Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Vaccines Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Vaccines Sales by Application (2019-2030)
5.1.1 Global Therapeutic Vaccines Sales by Application (2019-2024)
5.1.2 Global Therapeutic Vaccines Sales by Application (2025-2030)
5.1.3 Global Therapeutic Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Vaccines Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Vaccines Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Vaccines Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Northeast Biotherapeutics
6.1.1 Northeast Biotherapeutics Corporation Information
6.1.2 Northeast Biotherapeutics Description and Business Overview
6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio
6.1.5 Northeast Biotherapeutics Recent Developments/Updates
6.2 Agenus
6.2.1 Agenus Corporation Information
6.2.2 Agenus Description and Business Overview
6.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Agenus Therapeutic Vaccines Product Portfolio
6.2.5 Agenus Recent Developments/Updates
6.3 Vaccinogen Inc
6.3.1 Vaccinogen Inc Corporation Information
6.3.2 Vaccinogen Inc Description and Business Overview
6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Vaccinogen Inc Therapeutic Vaccines Product Portfolio
6.3.5 Vaccinogen Inc Recent Developments/Updates
6.4 CIMAB S.A
6.4.1 CIMAB S.A Corporation Information
6.4.2 CIMAB S.A Description and Business Overview
6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CIMAB S.A Therapeutic Vaccines Product Portfolio
6.4.5 CIMAB S.A Recent Developments/Updates
6.5 Dendreon
6.5.1 Dendreon Corporation Information
6.5.2 Dendreon Description and Business Overview
6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dendreon Therapeutic Vaccines Product Portfolio
6.5.5 Dendreon Recent Developments/Updates
6.6 Corixa
6.6.1 Corixa Corporation Information
6.6.2 Corixa Description and Business Overview
6.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Corixa Therapeutic Vaccines Product Portfolio
6.6.5 Corixa Recent Developments/Updates
6.7 AVAX Technologies
6.6.1 AVAX Technologies Corporation Information
6.6.2 AVAX Technologies Description and Business Overview
6.6.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AVAX Technologies Therapeutic Vaccines Product Portfolio
6.7.5 AVAX Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Vaccines Industry Chain Analysis
7.2 Therapeutic Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Vaccines Production Mode & Process
7.4 Therapeutic Vaccines Sales and Marketing
7.4.1 Therapeutic Vaccines Sales Channels
7.4.2 Therapeutic Vaccines Distributors
7.5 Therapeutic Vaccines Customers
8 Therapeutic Vaccines Market Dynamics
8.1 Therapeutic Vaccines Industry Trends
8.2 Therapeutic Vaccines Market Drivers
8.3 Therapeutic Vaccines Market Challenges
8.4 Therapeutic Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}